Private equity’s GTCR is selling Vernon Hills-based Antylia Scientific, a maker of molecular diagnostic reagents, specialty ...

In an interview with sister title Insurance Insider US, Aaron Cohen, head of financial services and technology at ...

Cohen said GTCR believes investors can still derive much value from broker consolidation plays in the UK and the US, but said ...

The FTC’s bid to block the private equity firm’s acquisition of Surmodics claims the tie-up would reduce competition in the ...

GTCR, a leading private equity firm, today announced that it has signed and completed the sale of Antylia Scientific ("Antylia" or "the Company") to Brookfield Asset Management's private equity ...

CHICAGO, May 28, 2025 /PRNewswire/ -- GTCR, a leading private equity firm, today announced that it has signed and completed the sale of Antylia Scientific ("Antylia" or "the Company") to ...

May 22 (Reuters) - Private equity firm GTCR is set to return more than $5 billion to its investors in the calendar year, a source familiar with the matter told Reuters on Thursday, after a string ...

Private equity firm GTCR is set to return more than $5 billion to its investors in the calendar year, a source familiar with the matter told Reuters on Thursday, after a string of strong exits sealed ...

Private equity firm GTCR has sold Antylia Scientific to Brookfield Asset Management ’s private equity business and Caisse de ...

CHICAGO, May 20, 2025 /PRNewswire/ -- GTCR, a leading private equity firm, announced that it has signed a definitive agreement to sell ITEL Laboratories, Inc. ("itel" or "the Company"), a leading ...